Latest Avelas Biosciences Stories
New CEO and Members Appointed to Board of Directors SAN DIEGO, Jan. 9, 2014 /PRNewswire/ -- Avelas Biosciences announced today the closing of a $6.85 million tranche of a Series B financing round - bringing the total funds raised since inception to ~$14 million. The funds will be used to support ongoing development of the Avelas Cancer Illuminator (ACI) candidate, AVB-620, through first-in-patient study. The financing was led by founding investor, Avalon Ventures, joined by new...
- Exultant; jubilant; triumphant; on the high horse.
- Tipsy; slightly intoxicated.